MS research funding awards given
The awards total over $1 million and will be distributed from two funds created by Merck Serono and Fast Forward to encourage early-stage drug discovery for MS: the Accelerating Commercial Development Fund to develop programs for for-profit entities, and the Accelerating Innovation Fund available to university-based investigators and seed-stage for-profit entities.
Under the Accelerating Innovation Fund the following awards were made:
- Howard Florey Institute in Australia will receive $275,000 over 12 months to advance the development of molecules that target Nav 1.6 ion channels.
- The Gladstone Institutes /UCSF will receive $300,000 to conduct testing for the identification of small molecule inhibitors of microglial activation.
The Accelerating Commercial Development Fund made the following award:
- Axxam of Italy will receive $430,590 over 18 months to advance the development of small molecules that target the sodium-calcium exchanger NCX1 on axons.